216 related articles for article (PubMed ID: 17429216)
1. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
Boison D
Neurodegener Dis; 2007; 4(1):28-33. PubMed ID: 17429216
[TBL] [Abstract][Full Text] [Related]
2. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.
Boison D
Neuroscientist; 2005 Feb; 11(1):25-36. PubMed ID: 15632276
[TBL] [Abstract][Full Text] [Related]
3. Adenosine kinase, epilepsy and stroke: mechanisms and therapies.
Boison D
Trends Pharmacol Sci; 2006 Dec; 27(12):652-8. PubMed ID: 17056128
[TBL] [Abstract][Full Text] [Related]
4. Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer.
Boison D; Scheurer L; Tseng JL; Aebischer P; Mohler H
Exp Neurol; 1999 Nov; 160(1):164-74. PubMed ID: 10630201
[TBL] [Abstract][Full Text] [Related]
5. Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches.
Pagonopoulou O; Efthimiadou A; Asimakopoulos B; Nikolettos NK
Neurosci Res; 2006 Sep; 56(1):14-20. PubMed ID: 16846657
[TBL] [Abstract][Full Text] [Related]
6. Adenosinergic system as an endogenous anticonvulsant mechanism.
Gupta YK; Malhotra J
Indian J Physiol Pharmacol; 1997 Oct; 41(4):329-43. PubMed ID: 10235655
[TBL] [Abstract][Full Text] [Related]
7. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants.
Li T; Steinbeck JA; Lusardi T; Koch P; Lan JQ; Wilz A; Segschneider M; Simon RP; Brüstle O; Boison D
Brain; 2007 May; 130(Pt 5):1276-88. PubMed ID: 17472985
[TBL] [Abstract][Full Text] [Related]
8. Adenosinergic signaling in epilepsy.
Boison D
Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
[TBL] [Abstract][Full Text] [Related]
9. Suppression of kindled seizures by paracrine adenosine release from stem cell-derived brain implants.
Güttinger M; Fedele D; Koch P; Padrun V; Pralong WF; Brüstle O; Boison D
Epilepsia; 2005 Aug; 46(8):1162-9. PubMed ID: 16060924
[TBL] [Abstract][Full Text] [Related]
10. Adenosine as a modulator of brain activity.
Boison D
Drug News Perspect; 2007 Dec; 20(10):607-11. PubMed ID: 18301794
[TBL] [Abstract][Full Text] [Related]
11. Focal treatment for refractory epilepsy: hope for the future?
Nilsen KE; Cock HR
Brain Res Brain Res Rev; 2004 Mar; 44(2-3):141-53. PubMed ID: 15003390
[TBL] [Abstract][Full Text] [Related]
12. Kappa opioids: therapeutic considerations in epilepsy and CNS injury.
Tortella FC; DeCoster MA
Clin Neuropharmacol; 1994 Oct; 17(5):403-16. PubMed ID: 9316689
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.
Boison D; Stewart KA
Biochem Pharmacol; 2009 Dec; 78(12):1428-37. PubMed ID: 19682439
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of antiepileptic drugs and new antiepileptic drugs].
Armijo JA; Adin J; Sánchez MB
Rev Neurol; 2006 Oct; 43 Suppl 1():S17-41. PubMed ID: 17061186
[TBL] [Abstract][Full Text] [Related]
15. The role of glial membrane ion channels in seizures and epileptogenesis.
D'Ambrosio R
Pharmacol Ther; 2004 Aug; 103(2):95-108. PubMed ID: 15369678
[TBL] [Abstract][Full Text] [Related]
16. Adenosine receptors in brain: neuromodulation and role in epilepsy.
Chin JH
Ann Neurol; 1989 Dec; 26(6):695-8. PubMed ID: 2690732
[TBL] [Abstract][Full Text] [Related]
17. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.
Vezzani A; Balosso S; Maroso M; Zardoni D; Noé F; Ravizza T
Curr Opin Investig Drugs; 2010 Jan; 11(1):43-50. PubMed ID: 20047158
[TBL] [Abstract][Full Text] [Related]
18. Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.
Boison D
Epilepsy Res; 2009 Aug; 85(2-3):131-41. PubMed ID: 19428218
[TBL] [Abstract][Full Text] [Related]
19. The adenosine kinase hypothesis of epileptogenesis.
Boison D
Prog Neurobiol; 2008 Mar; 84(3):249-62. PubMed ID: 18249058
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy.
Löscher W
Epilepsia; 2007 Jul; 48(7):1245-58. PubMed ID: 17441999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
